中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
26期
125-126
,共2页
芪参益心方%风湿性心脏病%慢性心力衰竭
芪參益心方%風濕性心髒病%慢性心力衰竭
기삼익심방%풍습성심장병%만성심력쇠갈
Qi Shen Qi Xin Fang%Rheumatic heart disease%Chronic heart failure
目的:研究分析风湿性心脏病慢性心衰患者接受芪参益心方治疗的效果。方法根据2013年1月~2014年1月我院的76例风湿性心脏病慢性心衰患者来进行研究分析,将这些患者分成对照组和治疗组,均有38例。对照组患者接受西药治疗,治疗组接受西药治疗和芪参益心方治疗,两组均接受四个疗程治疗,比较治疗结果。结果对照组治疗有效率是65.79%,治疗组有效率是81.58%,两组的治疗有效率存在统计学差异性(P<0.05);比较分析两组的超声心动图射血分值改善情况,结果为治疗组比对照组优秀(P<0.05)。结论风湿性心脏病慢性心衰是临床中比较难治疗的疾病,采取西药和芪参益心方联合治疗的方式具有比较高的治疗有效率,临床可以进一步的研究和探索。
目的:研究分析風濕性心髒病慢性心衰患者接受芪參益心方治療的效果。方法根據2013年1月~2014年1月我院的76例風濕性心髒病慢性心衰患者來進行研究分析,將這些患者分成對照組和治療組,均有38例。對照組患者接受西藥治療,治療組接受西藥治療和芪參益心方治療,兩組均接受四箇療程治療,比較治療結果。結果對照組治療有效率是65.79%,治療組有效率是81.58%,兩組的治療有效率存在統計學差異性(P<0.05);比較分析兩組的超聲心動圖射血分值改善情況,結果為治療組比對照組優秀(P<0.05)。結論風濕性心髒病慢性心衰是臨床中比較難治療的疾病,採取西藥和芪參益心方聯閤治療的方式具有比較高的治療有效率,臨床可以進一步的研究和探索。
목적:연구분석풍습성심장병만성심쇠환자접수기삼익심방치료적효과。방법근거2013년1월~2014년1월아원적76례풍습성심장병만성심쇠환자래진행연구분석,장저사환자분성대조조화치료조,균유38례。대조조환자접수서약치료,치료조접수서약치료화기삼익심방치료,량조균접수사개료정치료,비교치료결과。결과대조조치료유효솔시65.79%,치료조유효솔시81.58%,량조적치료유효솔존재통계학차이성(P<0.05);비교분석량조적초성심동도사혈분치개선정황,결과위치료조비대조조우수(P<0.05)。결론풍습성심장병만성심쇠시림상중비교난치료적질병,채취서약화기삼익심방연합치료적방식구유비교고적치료유효솔,림상가이진일보적연구화탐색。
ObjectiveTo study the effect of the treatment of chronic heart failure patients with rheumatic heart disease in patients with chronic heart failure. Methods According to our hospital from January 2013 to January 2014, 76 cases of rheumatic heart disease patients with chronic heart failure were analyzed, the patients were divided into control group and treatment group, 38 cases. The control group received western medicine treatment, the treatment group received western medicine treatment and the treatment of Qi Shen Yi Xin, the two groups were treated with four courses of treatment, compared the treatment results.ResultsThe effective rate of the control group was 65.79%, the effective rate of the treatment group was 81.58%, the effective rate of the two groups was statisticaly significant (P<0.05); the two groups were compared. The results were excelent in the treatment group than in the control group (P<0.05).Conclusion Rheumatic heart disease with chronic heart failure is a clinical difficult to treat the disease, take the western medicine and the treatment of Qi and the combination of Western medicine and the treatment of the patients with high efficiency, and can be further studied and explored.